m-TOR inhibitors and risk of Pneumocystis pneumonia after solid organ transplantation: a systematic review and meta-analysis Maryam GhadimiZinat MohammadpourAlireza Milajerdi Review 03 August 2019 Pages: 1471 - 1480
Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes—cardiovascular and renal benefits in patients with chronic kidney disease Tamara Y. MilderSophie L. StockerJerry R. Greenfield Review 03 August 2019 Pages: 1481 - 1490
Dose evaluation of intravenous metamizole (dipyrone) in infants and children: a prospective population pharmacokinetic study Victoria C. ZiesenitzFrédérique RodieuxMarc Pfister Clinical Trial 07 August 2019 Pages: 1491 - 1502
Effectiveness of using STOPP/START criteria to identify potentially inappropriate medication in people aged ≥ 65 years with chronic kidney disease: a randomized clinical trial Krystina ParkerIngrid Bull-EngelstadKnut Stavem Clinical Trial 29 July 2019 Pages: 1503 - 1511
Cinnarizine/betahistine combination vs. the respective monotherapies in acute peripheral vertigo: a randomized triple-blind placebo-controlled trial Payman AsadiSeyyed Mahdi Zia ZiabariSeyed Ahmad Naseri Alavi Clinical Trial 16 August 2019 Pages: 1513 - 1519
Evaluation of potential surrogate endpoints for prediction of overall survival in patients with castration-resistant prostate cancer: trial-level meta-analysis Wenjun ChenLiang LiTianyan Zhou Pharmacodynamics 28 August 2019 Pages: 1521 - 1532
CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic range proteinuria Hongxia LiuQinxia XuXiaoyan Qiu Pharmacogenetics 10 August 2019 Pages: 1533 - 1540
Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline Paulo Roberto Xavier TomazMariana Soares KajitaPaulo Caleb Júnior Lima Santos Pharmacogenetics 11 August 2019 Pages: 1541 - 1545
Breast milk concentration of hydroxychloroquine in Chinese lactating women with connective tissue diseases Wenxiu PengRongji LiuXiaoli Du Pharmacokinetics and Disposition 02 August 2019 Pages: 1547 - 1553
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort Aurélie Barrail-TranLauriane GoldwirtAudrey Coilly Pharmacokinetics and Disposition 05 August 2019 Pages: 1555 - 1563
Siponimod pharmacokinetics, safety, and tolerability in combination with the potent CYP3A4 inhibitor itraconazole in healthy subjects with different CYP2C9 genotypes Anne GardinKasra Shakeri-NejadSwati Dumitras Pharmacokinetics and Disposition 07 August 2019 Pages: 1565 - 1574
Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers Nut KoonrungsesomboonSaranyapin PotikanondJuntra Karbwang Pharmacokinetics and Disposition 19 August 2019 Pages: 1575 - 1582
Polypharmacy patterns in the last year of life in patients with dementia Rachel DenholmRichard MorrisRupert Payne Pharmacoepidemiology and Prescription Open access 25 July 2019 Pages: 1583 - 1591
Breast cancer and spironolactone: an observational postmarketing study Pierre SabatierJacques AmarJean-Louis Montastruc Pharmacoepidemiology and Prescription 15 August 2019 Pages: 1593 - 1598
Suspected adverse reactions associated with herbal products used for weight loss: spontaneous reports from the Italian Phytovigilance System Gabriela MazzantiAnnabella VitaloneFrancesca Menniti-Ippolito Pharmacoepidemiology and Prescription 19 August 2019 Pages: 1599 - 1615
Is vancomycin clearance really correlated with hemoglobin? Arguments that it’s not Maarten J. DeenenRob ter Heine Letter to the Editor 27 July 2019 Pages: 1617 - 1618
Response to: Is vancomycin clearance really correlated with hemoglobin? Arguments that it’s not Masayuki ChumaMakoto Makishima Letter to the Editor 24 July 2019 Pages: 1619 - 1620